trending Market Intelligence /marketintelligence/en/news-insights/trending/S_lmdlG_RSj540A1FWwurg2 content esgSubNav
In This List

OncoSec Medical falls out of Nasdaq compliance

Blog

Insight Weekly: Layoffs swell; energy efficiency PE deals defy downturn; 2023 global risk themes

Blog

Insight Weekly: Energy crisis cripples Europe; i-bank incomes rise; US holiday sales outlook

Blog

Japan M&A By the Numbers: Q3 2022

Blog

Insight Weekly: Reviving nuclear power; 2023 outlook for US financials; PE funds fuel EV sector


OncoSec Medical falls out of Nasdaq compliance

OncoSec Medical Inc. fell out of compliance with Nasdaq's $1 minimum bid price listing rule.

The Pennington, N.J.-based developer of cancer medicine has until June 19, 2019, with a possibility for extension, to regain compliance.

OncoSec Medical plans to evaluate available options to address the deficiency and regain compliance with the rule, the company said in a filing.